1. 100 Toward the Co-clinical Glioblastoma Treatment Paradigm—Radiomic Machine Learning Identifies Glioblastoma Gene Expression in Patients and Corresponding Xenograft Tumor Models. Issue Volume 65:Issue CN(2018)Supplement 1 (16th August 2018) Authors: Zinn, Pascal O; Singh, Sanjay K; Kotrotsou, Aikaterini; Hassan, Islam; Luedi, Markus M; Thomas, Ginu; Elshafeey, Nabil; Mosley, Jennifer; Elakkad, Ahmed; Idris, Tagwa; Gumin, Joy; Fuller, Gregory N; de Groot, John; Baladandayuthapani, Veera; Sulman, Erik P; Kumar, Ashok M; Sawaya, Raymond; Lang, ... Journal: Neurosurgery Issue: Volume 65:Issue CN(2018)Supplement 1 Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTR-34. INTEGRATED CLINICAL EXPERIENCE WITH ONC201 IN PREVIOUSLY-TREATED H3 K27M-MUTANT GLIOMA PATIENTS. (5th November 2018) Authors: Chi, Andrew; Arrillaga-Romany, Isabel; Gardner, Sharon; Wen, Patrick; Batchelor, Tracy; Hall, Matthew; Odia, Yazmin; Khatua, Soumen; Zaky, Wafik; McGovern, Susan; Harrison, Rebecca; de Groot, John; Sumrall, Ashley; Shonka, Nicole; Khatib, Zaid; Karajannis, Matthias; Mueller, Sabine; Tarapore, Roh... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-51. PHASE 2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND CLINICAL ACTIVITY OF PI3K/MTOR INHIBITOR GDC-0084 GIVEN TO GLIOBLASTOMA (GBM) PATIENTS WITH UNMETHYLATED O6-METHYLGUANINE-METHYLTRANSFERASE PROMOTER STATUS. (5th November 2018) Authors: Wen, Patrick; Cloughesy, Timothy; de Groot, John; Battiste, James; Garner, James; Simpson, Jeremy; Olivero, Alan; Gerstner, Elizabeth Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An expedited strategy for accurate and timely integrated molecular diagnosis of gliomas. Issue 4 (1st February 2023) Authors: Gregory, Timothy A; Williford, Garret L; Maronge, Jacob M; Alfaro, Kristin; Fuller, Gregory N; de Groot, John; Puduvalli, Vinay K; Ballester, Leomar Y; Majd, Nazanin K Journal: Neuro-oncology Issue: Volume 25:Issue 4(2023) Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Are we AKT-ually getting closer to making targeted therapy successful in breast cancer brain metastases?. Issue 11 (13th September 2019) Authors: Majd, Nazanin; Weathers, Shiao-Pei; de Groot, John Journal: Neuro-oncology Issue: Volume 21:Issue 11(2019) Page Start: 1344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ATIM-10. A PHASE I/II CLINICAL TRIAL OF AUTOLOGOUS CMV-SPECIFIC CYTOTOXIC T CELLS (CMV-TC) FOR GLIOBLASTOMA: DOSE ESCALATION AND CORRELATIVE RESULTS. (5th November 2018) Authors: Penas-Prado, Marta; Weathers, Shiao-Pei; Zhou, Shouhao; Kamiya-Matsuoka, Carlos; O'Brien, Barbara; Loghin, Monica; Harrison, Rebecca; Pei, Be Lian; Ictech, Sandra; Hunter, Kathy; Yung, W K Alfred; de Groot, John; Shpall, Elizabeth J; Heimberger, Amy; Rezvani, Katy Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL. (5th November 2018) Authors: Prins, Robert; Mochizuki, Aaron; Orpilla, Joey; Lee, Alexander; Davidson, Tom; Gaffey, Sarah; Sanders, Catherine; Rytlewski, Julie; Ellingson, Benjamin; Li, Gang; Yong, William; Clarke, Jennifer; Arrillaga-Romany, Isabel; Colman, Howard; Reardon, David; Kaley, Thomas; de Groot, John; Liau, Linda;... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ATIM-29. NRG BN002: SAFETY DATA FROM A PHASE I STUDY OF IPILIMUMAB (IPI), NIVOLUMAB (NIVO), AND THE COMBINATION FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM). (5th November 2018) Authors: Gilbert, Mark; Zhang, Peixin; Sloan, Andrew; Aldape, Kenneth; Wu, Jing; Rogers, Lisa; Wen, Patrick; Barani, Igor; Iwamoto, Fabio; Raval, Raju; Voloshin, Alfredo; de Groot, John; Won, Minhee; Mehta, Minesh P Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ATIM-37. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO; aPDL1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM). (5th November 2018) Authors: Weathers, Shiao-Pei; Kamiya-Matsuoka, Carlos; Dervin, Shannon; Yun, Cindy; Loghin, Monica; O'Brien, Barbara; Harrison, Rebecca; Yung, W K Alfred; Penas-Prado, Marta; de Groot, John Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastoma. (2nd September 2019) Authors: Majd, Nazanin; de Groot, John Journal: Expert opinion on pharmacotherapy Issue: Volume 20:Number 13(2019) Page Start: 1609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗